13 Jan 2023 Ziphius Vaccines appoints former head of Janssen Vaccines R&D as Chief Scientific Advisor Member news
13 Jan 2023 Mayne Pharma and Mithra announce US launch of HALOETTE®, a generic version of NUVARING® Member news
13 Jan 2023 InnoSer expands its preclinical neuroscience expertise with the acquisition of Sylics Member news
13 Jan 2023 FOx BIOSYSTEMS raises € 5.8 million in B-round financing to scale up its operations Member news
10 Jan 2023 ExeVir Bio secures EUR 25 million venture debt financing from the European Investment Bank Member news
09 Jan 2023 Foundational RNA and cLNP expert Antonin (Tony) de Fougerolles joins eTheRNA as independent board member Member news
06 Jan 2023 UCB announces rozanolixizumab BLA for the treatment of generalized myasthenia gravis filed with U.S. FDA and designated for Priority Review Member news
23 Dec 2021 Peter Scheyltjens (52), CEO en oprichter van de Advipro Groep, geeft de fakkel door aan zijn rechterhand Toon Witvrouwen (35) Member news
More info? Ellen Telleir Communications Project Manager linkedin.com/in/ellentelleir/ ellen.telleir@biovia.be Contact us
